Table 4 IPTp timing inconsistencies within countries*
National malaria policy | National malaria guidelines | National RH policy | National RH guidelines | In-service training materials | Supervision materials | Pre-service curricula | Weeks during which providers can give IPTp-SP (# weeks during which IPT-SP can be given) | |
|---|---|---|---|---|---|---|---|---|
Kenya | No guidance | Each scheduled visit after quickening up to 40 weeks | No guidance | No guidance | Each scheduled visit after quickening up to 40 weeks | Each scheduled visit after quickening up to 40 weeks | Not available | 16–40 weeks (24 weeks) |
Mali | No guidance | Twice after 16 weeks; no upper limit | Combined with RH guidelines, thus: IPTp-SP at 24–28 and 32–36 weeks | IPTp-SP at 24–28 and 32–36 weeks | Two doses between the 4th and 8th months of pregnancy, up to 36 weeks | Give between 4th and 8th months, number of doses not mentioned | Not available | Ranges from 16–40 weeks (24 weeks); from 24–28 and 32–36 weeks (8 weeks); and between the 4th–8th months (16 weeks) |
Mozambique | No guidance | Two doses after 20 weeks | No guidance | Three doses after 20 weeks | Give after 20 weeks | Three doses after 20 weeks | Three doses after 20 weeks | Give between 20–40 weeks; (20 weeks) |
Mainland Tanzania | No guidance | 1st dose 20–24 weeks, 2nd 28–32 weeks | No guidance | No guidance | 1st dose 20–24 weeks, 2nd 28–32 weeks | 1st dose 20–24 weeks, 2nd 28–32 weeks | 1st dose 20 – 24 weeks, 2nd 28 – 32 weeks | Give between 20–24 and 28–32 weeks (8 weeks) |
Uganda | No guidance | 1st dose 4th–6th month, 2nd dose 7th–9th months | 1st dose at 24–28 weeks; 2nd before 32 weeks | No guidance | 1st dose at 16–24 weeks; 2nd dose at 28–34 weeks | No guidance | Not available | Ranges from 4th–9th months (24 weeks); between 24–28 weeks and before 32 weeks (8 weeks); and between 16–24 and 28–34 weeks (14 weeks) |